Literature DB >> 23106770

Perceived burden and neuropsychiatric morbidities in adults with 22q11.2 deletion syndrome.

D J Karas1, G Costain, E W C Chow, A S Bassett.   

Abstract

BACKGROUND: 22q11.2 deletion syndrome (22q11.2DS) is a common genetic subtype of intellectual disability (ID) remarkable for its constellation of congenital, developmental and later-onset features. Survival to adulthood is now the norm, and serious psychiatric illness is common in adults. However, little is known about the experiences and perceived needs of individuals with 22q11.2DS and their caregivers at time of transition from paediatric to adult models of care and beyond.
METHOD: We administered a mail survey to 84 caregivers of adults with 22q11.2DS and 34 adult patients themselves, inquiring about medical and social services, perceived burden and major challenges in adulthood in 22q11.2DS. Standard quantitative and qualitative methods were used to analyse the responses.
RESULTS: Fifty-three (63.1%) caregivers and 20 (58.8%) adults with 22q11.2DS completed the survey. Perceived burden was high, with psychiatric illness and/or behavioural issues considered the most challenging aspects of adulthood in 22q11.2DS by the majority of caregivers (70.0%) and many patients themselves (42.9%). Irrespective of the extent of ID and the presence or absence of other major features, caregivers expressed dissatisfaction with medical and social services for adults, including at time of transition from paediatric care.
CONCLUSIONS: To our knowledge, this is the first study to examine the subjective experiences of adults with 22q11.2DS and their caregivers and to identify their perceived needs for services. Better awareness of 22q11.2DS and its later-onset manifestations, early diagnosis and treatment of psychiatric illness, additional support at time of transition and dedicated clinics for adults with 22q11.2DS may help to improve patient outcomes and reduce caregiver burden.
© 2012 The Authors. Journal of Intellectual Disability Research © 2012 John Wiley & Sons Ltd, MENCAP & IASSIDD.

Entities:  

Keywords:  22q11.2 deletion syndrome; adult; burden; caregivers; intellectual disability; schizophrenia

Mesh:

Year:  2012        PMID: 23106770      PMCID: PMC4516411          DOI: 10.1111/j.1365-2788.2012.01639.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  39 in total

1.  Recognizing a common genetic syndrome: 22q11.2 deletion syndrome.

Authors:  Ronak K Kapadia; Anne S Bassett
Journal:  CMAJ       Date:  2008-02-12       Impact factor: 8.262

2.  Parents' perceptions of postschool years for young adults with developmental disabilities.

Authors:  Margarita Bianco; Dorothy F Garrison-Wade; Romie Tobin; Jean P Lehmann
Journal:  Intellect Dev Disabil       Date:  2009-06

3.  Premature death in adults with 22q11.2 deletion syndrome.

Authors:  A S Bassett; E W C Chow; J Husted; K A Hodgkinson; E Oechslin; L Harris; C Silversides
Journal:  J Med Genet       Date:  2009-02-25       Impact factor: 6.318

4.  Factors related to perceived needs of primary caregivers of patients with schizophrenia.

Authors:  Ling-Ling Yeh; Hai-Gwo Hwu; Chun-Houh Chen; Chen-Hsin Chen; Agnes C C Wu
Journal:  J Formos Med Assoc       Date:  2008-08       Impact factor: 3.282

Review 5.  Mathematical learning disabilities in children with 22q11.2 deletion syndrome: a review.

Authors:  Bert De Smedt; Ann Swillen; Lieven Verschaffel; Pol Ghesquière
Journal:  Dev Disabil Res Rev       Date:  2009

6.  Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Christian R Marshall; Anath C Lionel; Eva W C Chow; Stephen W Scherer
Journal:  Hum Mol Genet       Date:  2008-09-20       Impact factor: 6.150

7.  Parent views on enhancing the quality of health care for their children with fragile X syndrome, autism or Down syndrome.

Authors:  P Minnes; K Steiner
Journal:  Child Care Health Dev       Date:  2009-03       Impact factor: 2.508

Review 8.  The burden of schizophrenia on caregivers: a review.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

9.  Extracardiac features predicting 22q11.2 deletion syndrome in adult congenital heart disease.

Authors:  Wai Lun Alan Fung; Eva W C Chow; Gary D Webb; Michael A Gatzoulis; Anne S Bassett
Journal:  Int J Cardiol       Date:  2008-01-11       Impact factor: 4.164

10.  Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart disease in the UK: cross-sectional, population-based study with case-control analysis.

Authors:  J Billett; M R Cowie; M A Gatzoulis; I F Vonder Muhll; A Majeed
Journal:  Heart       Date:  2007-07-23       Impact factor: 5.994

View more
  12 in total

Review 1.  Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series.

Authors:  Nancy J Butcher; Erik Boot; Anthony E Lang; Danielle Andrade; Jacob Vorstman; Donna McDonald-McGinn; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2018-05-19       Impact factor: 2.802

2.  Reproductive Health Issues for Adults with a Common Genomic Disorder: 22q11.2 Deletion Syndrome.

Authors:  Chrystal Chan; Gregory Costain; Lucas Ogura; Candice K Silversides; Eva W C Chow; Anne S Bassett
Journal:  J Genet Couns       Date:  2015-01-13       Impact factor: 2.537

3.  Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting.

Authors:  Anne S Bassett; Gregory Costain; Christian R Marshall
Journal:  Prenat Diagn       Date:  2016-11-14       Impact factor: 3.050

4.  Parents' perspectives, experiences, and need for support when communicating with their children about the psychiatric manifestations of 22q11.2 deletion syndrome (22q11DS).

Authors:  Courtney B Cook; Caitlin Slomp; Jehannine Austin
Journal:  J Community Genet       Date:  2021-11-16

5.  Medical, welfare, and educational challenges and psychological distress in parents caring for an individual with 22q11.2 deletion syndrome: A cross-sectional survey in Japan.

Authors:  Ryo Morishima; Yousuke Kumakura; Satoshi Usami; Akiko Kanehara; Miho Tanaka; Noriko Okochi; Naomi Nakajima; Junko Hamada; Tomoko Ogawa; Shuntaro Ando; Hidetaka Tamune; Mutsumi Nakahara; Seiichiro Jinde; Yukiko Kano; Kyoko Tanaka; Yoichiro Hirata; Akira Oka; Kiyoto Kasai
Journal:  Am J Med Genet A       Date:  2021-09-03       Impact factor: 2.578

6.  Communication of Psychiatric Risk in 22q11.2 Deletion Syndrome: A Pilot Project.

Authors:  Sarah J Hart; Kelly Schoch; Vandana Shashi; Nancy Callanan
Journal:  J Genet Couns       Date:  2015-11-18       Impact factor: 2.537

Review 7.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

Review 8.  Practical guidelines for managing adults with 22q11.2 deletion syndrome.

Authors:  Wai Lun Alan Fung; Nancy J Butcher; Gregory Costain; Danielle M Andrade; Erik Boot; Eva W C Chow; Brian Chung; Cheryl Cytrynbaum; Hanna Faghfoury; Leona Fishman; Sixto García-Miñaúr; Susan George; Anthony E Lang; Gabriela Repetto; Andrea Shugar; Candice Silversides; Ann Swillen; Therese van Amelsvoort; Donna M McDonald-McGinn; Anne S Bassett
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

9.  The psychosocial impact of 22q11 deletion syndrome on patients and families: A systematic review.

Authors:  Oanh Kieu Vo; Alisdair McNeill; Katharina Sophie Vogt
Journal:  Am J Med Genet A       Date:  2018-03-25       Impact factor: 2.802

10.  All-cause mortality and survival in adults with 22q11.2 deletion syndrome.

Authors:  Lily Van; Tracy Heung; Justin Graffi; Enoch Ng; Sarah Malecki; Spencer Van Mil; Erik Boot; Maria Corral; Eva W C Chow; Kathleen A Hodgkinson; Candice Silversides; Anne S Bassett
Journal:  Genet Med       Date:  2019-04-05       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.